Wei Zou
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 36
- Cancer Immunotherapy and Biomarkers 27
- Colorectal Cancer Treatments and Studies 7
- Polyomavirus and related diseases 4
-
- Lung Cancer Treatments and Mutations 14
- Co-authors
- Marcin Kowanetz (15 shared papers)Marcus Ballinger (7 shared papers)Achim Rittmeyer (6 shared papers)Alan Sandler (5 shared papers)Alexander I. Spira (4 shared papers)Daniel Waterkamp (4 shared papers)Louis Fehrenbacher (3 shared papers)Daniel S. Chen (3 shared papers)
- Journals
- Journal of Thoracic Oncology (5 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (4 papers)PLoS ONE (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Wei Zou
50 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 3.1k
- Pulmonary and Respiratory Medicine 2.0k
- Cancer Research 683
- Immunology 831
- Pathology and Forensic Medicine 169
Countries citing papers authored by Wei Zou
This map shows the geographic impact of Wei Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zou more than expected).
Fields of papers citing papers by Wei Zou
This network shows the impact of papers produced by Wei Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zou. The network helps show where Wei Zou may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial Hit paper breakdown → | 2016 | 2112 |
| 2 | Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study Hit paper breakdown → | 2016 | 409 |
| 3 | IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC Hit paper breakdown → | 2021 | 316 |
| 4 | 2022 | 91 | |
| 5 | 2023 | 75 | |
| 6 | 2017 | 62 | |
| 7 | 2017 | 61 | |
| 8 | 2020 | 55 | |
| 9 | 2017 | 43 | |
| 10 | 2021 | 35 | |
| 11 | 2016 | 34 | |
| 12 | 2017 | 30 | |
| 13 | 2015 | 28 | |
| 14 | 2020 | 26 | |
| 15 | 2023 | 25 | |
| 16 | 2016 | 25 | |
| 17 | 2016 | 23 | |
| 18 | 2016 | 22 | |
| 19 | 2019 | 14 | |
| 20 | 2023 | 13 |
About Wei Zou
Wei Zou is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Immunology, having authored 60 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Lung Cancer Treatments and Mutations (14 papers), Cancer Genomics and Diagnostics (13 papers), Colorectal Cancer Treatments and Studies (7 papers), Immunotherapy and Immune Responses (5 papers), Polyomavirus and related diseases (4 papers), Full-Duplex Wireless Communications (4 papers) and Natural Compounds in Disease Treatment (3 papers). The work is most often cited by research in Oncology (3.1k citations), Pulmonary and Respiratory Medicine (2.0k citations), Cancer Research (683 citations), Immunology (831 citations) and Pathology and Forensic Medicine (169 citations). Wei Zou has collaborated with scholars based in United States, China and France. Frequent co-authors include Marcin Kowanetz, Marcus Ballinger, Achim Rittmeyer, Alan Sandler, Alexander I. Spira, Daniel Waterkamp, Louis Fehrenbacher, Daniel S. Chen, Jing Yi and Keunchil Park. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Annals of Oncology, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.